Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Jun 10, 2014

Why Big Pharma Needs Blockbusters

Orphan drugs are one way it aims to get them.

Why Big Pharma Needs Blockbusters

Orphan drugs—drugs for rare diseases—can be blockbusters if priced high enough. [© Orlando Florin Rosu - Fotolia.com]

  • The word “blockbuster” is reserved for drugs with over one billion dollars in yearly sales. From big pharma’s own discovery and development (DD&D) data, ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »